Tuesday, October 23, 2018

Google Alert - cancer

Google
cancer
Daily update October 23, 2018
NEWS
New approaches to tame the immune system in the fight against cancer are getting us closer to a future where cancer becomes a curable disease.
Google Plus Facebook Twitter Flag as irrelevant
Allison's breakthrough was the discovery of a sort of secret handshake that cancer uses to evade the immune system, and a means to block that ...
Google Plus Facebook Twitter Flag as irrelevant
Immunotherapy, treatment used to help boost the body's immune system, allowed some patients with an aggressive form of breast cancer to live ...
Google Plus Facebook Twitter Flag as irrelevant
A new study, published in the Journal of Experimental & Clinical Cancer Research, finds that a synthetic analog of a compound found in a rare ...
Google Plus Facebook Twitter Flag as irrelevant
Gwen Blum got the news from a cousin about a year ago. Her cousin's grandmother had died of breast cancer in her early 50s. The grandmother's ...
Google Plus Facebook Twitter Flag as irrelevant
Since I began writing here at Forbes, it's become harder to keep up with new oncology drugs. So many medicines are being tested, who can keep ...
Google Plus Facebook Twitter Flag as irrelevant
Connor McMahon hasn't even hit 18, and he's already beat cancer three times. But rather than dwell on a childhood marked by acute lymphoblastic ...
Google Plus Facebook Twitter Flag as irrelevant
(CNN) Ryan Murphy has revealed his young son battled cancer and announced a major donation to the hospital he feels saved his son's life.
Google Plus Facebook Twitter Flag as irrelevant
Bowel cancer is on the increase among young people in Europe, researchers have discovered, with expanding waistlines thought to play a role in the ...
Google Plus Facebook Twitter Flag as irrelevant
"She's the youngest breast cancer patient that I have right now," Dr. Andrew Johnson, a hematology and oncology physician at the Longstreet Clinic.
Google Plus Facebook Twitter Flag as irrelevant
Kelly-Green is not just a cancer survivor, she's also a well-known philanthropist in Memphis. After retiring from FedEx, she's now the owner of several ...
Google Plus Facebook Twitter Flag as irrelevant
ESMO 2018 abstract LBA21 - "InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus ...
Google Plus Facebook Twitter Flag as irrelevant
Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings highlight the need for continued efforts to ...
Google Plus Facebook Twitter Flag as irrelevant
A Northern California judge on Monday upheld a jury's verdict that found Monsanto's weed killer caused a groundskeeper's cancer, but she slashed ...
Google Plus Facebook Twitter Flag as irrelevant
Popular WWE wrestler Roman Reigns made an emotional announcement on the nationally televised WWE "Raw" TV show Monday night, telling the ...
Google Plus Facebook Twitter Flag as irrelevant
Mirati Therapeutics (MRTX) and Clovis Oncology (CLVS) dragged biotech companies into a pitfall Monday after studies of their cancer treatments ...
Google Plus Facebook Twitter Flag as irrelevant
"Guys, I can't go get margaritas with you. I have cancer." These were the words that stumbled out of Rebecca Scheinkman's mouth as she wrestled ...
Google Plus Facebook Twitter Flag as irrelevant
It is presumed that anticipated regulatory and reimbursement policies are important considerations in the research and development (R&D) decisions ...
Google Plus Facebook Twitter Flag as irrelevant
Experts have warned of a "woeful" lack of awareness of the symptoms of ovarian cancer after a study revealed two thirds of women had never heard of ...
Google Plus Facebook Twitter Flag as irrelevant
A novel cell-based immunotherapy using a switch control approach eradicated pancreatic cancer cells in mice, including cancer cells that had already ...
Google Plus Facebook Twitter Flag as irrelevant
Treating cancer patients who are HIV-positive with immunotherapy agents is safe and feasible, according to a new study. CD4 lymphocyte count and ...
Google Plus Facebook Twitter Flag as irrelevant
Cancer is a deadly condition that's caused by cells growing and reproducing uncontrollably. These cancerous cells can destroy surrounding tissue, ...
Google Plus Facebook Twitter Flag as irrelevant
However, about a third of people do not respond initially, and another 40 to 50 percent relapse (their cancer comes back) after an initial response.
Google Plus Facebook Twitter Flag as irrelevant
(PHILADELPHIA) - Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel ...
Google Plus Facebook Twitter Flag as irrelevant
When Terry Gallant, 71, of El Cajon received a Stage 4 Lymphoma cancer diagnosis, he had tumors in his body so large that he couldn't sleep on his ...
Google Plus Facebook Twitter Flag as irrelevant
This is good news for Novartis because it will help it expand its cancer product pipeline. In addition, it complements another acquisition that also ...
Google Plus Facebook Twitter Flag as irrelevant
s cancer drug Opdivo BMY, -5.53% The trial enrolled patients with non-small cell lung cancer who had their cancer progress while taking a type of ...
Google Plus Facebook Twitter Flag as irrelevant
Detecting cancer that has spread from the primary site to nearby lymph nodes is a laborious process, particularly in the case of breast cancer. For this ...
Google Plus Facebook Twitter Flag as irrelevant
Already famous at Purdue and in Central Indiana, Tyler Trent captured the attention of Vice President Mike Pence this month and went international on ...
Google Plus Facebook Twitter Flag as irrelevant
Editor's note: Contact7 seeks out audience tips and feedback to help people in need, resolve problems and hold the powerful accountable. If you know ...
Google Plus Facebook Twitter Flag as irrelevant
A combination cancer immunotherapy from French biotech Innate Pharma was twice as effective at treating recurrent squamous cell carcinoma as ...
Google Plus Facebook Twitter Flag as irrelevant
Cancer care requires many medical visits--making an overwhelming diagnosis even more life-changing. "Cancer takes a lot of things from us, even ...
Google Plus Facebook Twitter Flag as irrelevant
Bristol-Myers said the marketing application for its Opdivo plus Yervoy cancer therapy combination will be delayed by three months, until May 2019.
Google Plus Facebook Twitter Flag as irrelevant
26, was diagnosed with neuroblastoma, an aggressive form of pediatric cancer, when she was 6 weeks old. Leah's family and friends are planning the ...
Google Plus Facebook Twitter Flag as irrelevant
Raw Video: The University of Kansas Cancer Center asks general public for help in recovering inflatable colon. The inflatable colon which teaches the ...
Google Plus Facebook Twitter Flag as irrelevant
WEB
Activating Your Immune System Against Cancer
What can be done when cancer is able to hide from your immune system or block the immune response, or if it just isn't strong enough to kill all the ...
Google Plus Facebook Twitter Flag as irrelevant
Spatiotemporal loss of NF1 in Schwann cell lineage leads to different types of cutaneous ...
Neurofibromatosis type 1 (NF1) is a cancer predisposition disorder that results from inactivation of the tumor-suppressor Neurofibromin, a negative ...
Google Plus Facebook Twitter Flag as irrelevant
Stephenson Cancer Center Leads Groundbreaking Ovarian Cancer Study
A physician-scientist at Stephenson Cancer Center at OU Medicine co-directed an international clinical trial that yielded findings considered ...
Google Plus Facebook Twitter Flag as irrelevant
Cancer
Printable and downloadable resources with information on cancers that affect women.
Google Plus Facebook Twitter Flag as irrelevant
Caring for cancer patients at the age of 13
His passion for treating cancer patients at Advocate Lutheran General Hospital in Park Ridge, Ill., has sparked a similar passion in his granddaughter.
Google Plus Facebook Twitter Flag as irrelevant
preoperative immunotherapy colon cancer
Major response to immunotherapy in early-stage mismatch repair deficient colon cancer [ESMO 2018 Press Release] ...
Google Plus Facebook Twitter Flag as irrelevant
Google has built a 'spell check'
Tissue taken from the lymph nodes can be a way of detecting whether a patients' breast cancer has spread beyond the breasts. Pathologists then look ...
Google Plus Facebook Twitter Flag as irrelevant
Dr. Cowan to step down as cancer center director
The man who helped spearhead the ascent of UNMC/Nebraska Medicine into an international powerhouse for cancer care and research -- Ken ...
Google Plus Facebook Twitter Flag as irrelevant
Cancer Immunotherapy Is Safe for People With HIV
As people with HIV live longer thanks to effective antiretroviral therapy, non-AIDS-related cancers have become a major cause of illness and death.
Google Plus Facebook Twitter Flag as irrelevant
Prostate radiotherapy can benefit some men whose cancer has spread
Treating the prostate with radiotherapy alongside standard treatment substantially improves survival for some men with advanced prostate cancer, ...
Google Plus Facebook Twitter Flag as irrelevant
Giant Inflatable Colon Stolen From University of Kansas Cancer Center
The 10-foot colon, which cost around $4000, was used to teach people about colon cancer.
Google Plus Facebook Twitter Flag as irrelevant
Program Manager, Global Cancer Treatment
The American Cancer Society's Global Cancer Treatment program works to improve access to cancer treatment in low and middle-income countries.
Google Plus Facebook Twitter Flag as irrelevant
Mastectomy Article from US News & World Report
Great article from US News & World Report…. Do I Have to Reconstruct My Breast After a Mastectomy? 'Going flat' is a good option for many breast ...
Google Plus Facebook Twitter Flag as irrelevant
Siteman Cancer Center to offer newest form of proton therapy
Cancer patients in Missouri, Southern Illinois and beyond will have access to a new generation of proton therapy in early 2020. Known as pencil-beam ...
Google Plus Facebook Twitter Flag as irrelevant
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

No comments:

Post a Comment